What does CUSIP 15117P102 represent in this 13F holders report?

CUSIP 15117P102 is the security identifier for CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW used to aggregate holder disclosures.

How many institutions held CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in Q2 2021?

No institutional holders were reported for CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in Q2 2021; review adjacent reporting periods for trend context.

CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG)

CUSIP: 15117P102

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / COM NEW
Total 13F shares: 0
Share change: -6,300
Total reported value: $0
Number of holders: 0
Value change: -$116,000
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 15117P102?
CUSIP 15117P102 identifies CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q1 2021

Recent filing periods for CUSIP 15117P102:

Q2 2021 Q1 2021 Q4 2020 Q3 2020 Q2 2020 Q1 2020 Q4 2019 Q3 2019

CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG)

Q2 2021 13F Holders as of 30 Jun 2021

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW as of Q2 2021.